Iminochromene inhibitors of dynamins I and II GTPase activity and endocytosis

Timothy A. Hill, Anna Mariana, Christopher P. Gordon, Luke R. Odell, Mark J. Robertson, Aandrew B. McGeachie, Ngoc Chau, James A. Daniel, Nick N. Gorgani, Phillip J. Robinson, Adam McCluskey

    Research output: Contribution to journalArticlepeer-review

    57 Citations (Scopus)

    Abstract

    Herein we report the synthesis of discrete iminochromene ("iminodyn") libraries (14-38) as potential inhibitors of dynamin GTPase. Thirteen iminodyns were active (IC50 values of 260 nM to 100 μM), with N,N-(ethane-1,2-diyl)bis(7,8-dihydroxy-2-iminochromene-3-carboxamide) (17), N,N-(ethane-1,2-diyl)bis(7,8-dihydroxy-2-iminochromene-3-carboxamide) (22), and N,N-(ethane-1,2-diyl)bis(7,8-dihydroxy-2-iminochromene-3-carboxamide) (23) (IC50 values of 330 ± 70, 450 ± 50, and 260 ± 80 nM, respectively) being the most potent. Five of the most potent iminodyns all inhibited dynamins I and II approximately equally. Iminodyn-22 displayed uncompetitive inhibition with respect to GTP. Selected iminodyns were evaluated for their ability to block receptor mediated endocytosis (RME, mediated by dynamin II) and synaptic vesicle endocytosis (SVE, mediated by dynamin I), with 17 showing no activity while 22 returned RME and SVE IC50 values of 10.7 ± 4.5 and 99.5 ± 1.7 μM, respectively. The iminodyns reported herein represent a new chemical class of the first nanomolar potent dynamin inhibitors that are also effective endocytosis inhibitors.
    Original languageEnglish
    Pages (from-to)4094-4102
    Number of pages9
    JournalJournal of Medicinal Chemistry
    Volume53
    Issue number10
    DOIs
    Publication statusPublished - 2010

    Fingerprint

    Dive into the research topics of 'Iminochromene inhibitors of dynamins I and II GTPase activity and endocytosis'. Together they form a unique fingerprint.

    Cite this